Whey protein augments leucinemia and postexercise p70s6k1 activity compared with a hydrolyzed collagen blend when in recovery from training with low carbohydrate availability by Impey, Samuel et al.
1 
 
 
 1 
 2 
Whey protein augments leucinemia and post-exercise p70S6K1 activity 3 
compared to a hydrolysed collagen blend when in recovery from training with 4 
low carbohydrate availability 5 
 6 
Samuel G Impey1, Kelly M Hammond1, Robert Naughton1, Carl Langan-Evans1, Sam O 7 
Shepherd1, Adam P Sharples1, Jessica Cegielski2, Kenneth Smith2, Stewart Jeromson3, D Lee 8 
Hamilton3, Graeme L Close1 and James P Morton1 9 
 10 
1Research Institute for Sport and Exercise Sciences 11 
Liverpool John Moores University 12 
Tom Reilly Building 13 
Byrom St Campus 14 
Liverpool 15 
L3 3AF 16 
UK 17 
 18 
2MRC-ARUK Centre for Musculoskeletal Aging 19 
Research Division of Medical Sciences and Graduate Entry Medicine  20 
School of Medicine Faculty of Medicine and Health Sciences 21 
University of Nottingham 22 
Royal Derby Hospital Centre 23 
Derby 24 
DE22 3DT 25 
 26 
3Health and Exercise Sciences Research Group 27 
University of Stirling 28 
Stirling  29 
FK9 4LA 30 
 31 
Running Title: CHO restriction, leucine and cell signalling 32 
 33 
Address for correspondence: 34 
Dr James Morton 35 
Research Institute for Sport and Exercise Sciences 36 
Liverpool John Moores University 37 
Tom Reilly Building  38 
Byrom St Campus 39 
Liverpool 40 
L3 3AF 41 
United Kingdom 42 
Email: J.P.Morton@ljmu.ac.uk 43 
Tel: +44 151 904 6233 44 
2 
 
 
Abstract 45 
We examined the effects of whey versus collagen protein on skeletal muscle cell signalling 46 
responses associated with mitochondrial biogenesis and protein synthesis in recovery from an 47 
acute training session completed with low carbohydrate (CHO) availability. In a repeated 48 
measures design (after adhering to a 36-h exercise-dietary intervention to standardise pre-49 
exercise muscle glycogen), eight males completed a 75-min non-exhaustive cycling protocol 50 
and consumed 22 g of a hydrolysed collagen blend (COLLAGEN) or whey (WHEY) protein 51 
45 min prior to exercise, 22 g during exercise and 22 g immediately post-exercise. Exercise 52 
decreased (P<0.05) muscle glycogen content by comparable levels from pre-to post-exercise 53 
in both trials (≈ 300 to 150 mmol.kg-1 dw). WHEY protein induced greater increases in plasma 54 
BCAAs (P=0.03) and leucine (P=0.02) than COLLAGEN.  Exercise induced (P<0.05) similar 55 
increases in PGC-1α (5-fold) mRNA at 1.5 h post-exercise between conditions though no affect 56 
of exercise (P>0.05) was observed for p53, Parkin and Beclin1 mRNA. Exercise suppressed 57 
(P<0.05) p70S6K1 activity in both conditions immediately post-exercise (≈ 25 fmol.min-1.mg-58 
1). Post-exercise feeding increased p70S6K1 activity at 1.5 h post-exercise (P<0.05), the 59 
magnitude of which was greater (P <0.05) in WHEY (180 ± 105 fmol.min-1.mg-1) versus 60 
COLLAGEN (73 ± 42 fmol.min-1.mg-1). We conclude that protein composition does not 61 
modulate markers of mitochondrial biogenesis when in recovery from a training session 62 
deliberately completed with low CHO availability. In contrast, whey protein augments post-63 
exercise p70S6K activity compared with hydrolysed collagen, as likely mediated via increased 64 
leucine availability.  65 
Keywords: autophagy, p70S6K1, CHO restriction, glycogen 66 
 67 
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Introduction  69 
The role of increased dietary protein intake in facilitating skeletal muscle adaptations 70 
associated with endurance training is now gaining acceptance (Moore et al. 2014).  Indeed, 71 
consuming protein before (Coffey et al. 2011), during (Hulston et al. 2011) and/or after 72 
(Rowlands et al. 2015) an acute training session stimulates muscle protein synthesis 73 
(MPS).  Post-exercise protein feeding has also been shown to modify skeletal muscle 74 
transcriptome responses towards those supporting the endurance phenotype (Rowlands et al. 75 
2011).  In considering protein-feeding strategies for athletes, it is pertinent to consider the 76 
absolute dose (Moore et al. 2009; Witard et al. 2014; Rowlands et al. 2015; MacNaughton et 77 
al. 2016), feeding schedule (West et al., 2011; Areta et al. 2013), digestibility (Burke et al. 78 
2012; Phillips, 2016) and source of protein (Tang et al. 2009; Wilkinson et al. 2007).  79 
Contemporary guidelines recommend whey protein beverages due to its higher leucine content 80 
and rapid aminoacidemia upon ingestion (Thomas et al. 2016), though hydrolysed collagen 81 
beverages and gels are now commercially available and marketed to athletic populations. 82 
Whilst the use of a gel delivery matrix appears particularly beneficial for endurance athletes 83 
given the practical advantages of feeding while in locomotion (Impey et al. 2015), it is 84 
noteworthy that collagen based formulations likely have lower leucine content and digestibility 85 
compared with whey (Phillips, 2016). 86 
With this in mind, the aim of the present study was to therefore examine the effects of two 87 
practically relevant protein-feeding strategies (i.e. whey protein solution versus a hydrolysed 88 
collagen blend in a gel format) in modulating skeletal muscle cell signalling responses 89 
associated with mitochondrial biogenesis and MPS.  Given the increased popularity of training 90 
with low carbohydrate (CHO) availability (i.e. the train-low paradigm) in an attempt to enhance 91 
mitochondrial related adaptations (Hawley and Morton, 2014; Bartlett et al. 2015; Impey et al. 92 
2016; 2018), we adopted an experimental design whereby male cyclists completed a non-93 
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exhaustive training session in which glycogen remained within an absolute concentration (i.e. 94 
pre-and post-exercise concentrations of <350 and >100 mmol.kg dw-1, respectively) considered 95 
representative of train-low conditions (Impey et al. 2018).   96 
 97 
Methodology  98 
Subjects: After providing informed written consent, eight recreational male cyclists (age: 25 ± 99 
3 years; height: 175 ± 0.1 cm; body mass: 74.4 ± 6.7 kg) who trained between 3 – 10 hours per 100 
week took part in this study. Mean VO2peak and peak power output (PPO) was 56.5 ± 3.8 ml.kg
-101 
1.min-1 and 327 ± 26 W respectively. None of the participants had a history of neurological 102 
disease or skeletal muscle abnormality and none were under pharmacological intervention 103 
during the study. The study was approved by the Research Ethics Committee of Liverpool John 104 
Moores University.  105 
Design: In a repeated measures counterbalanced design separated by 7-9 days, subjects 106 
completed two non-exhaustive acute exercise trials in conditions of reduced CHO availability 107 
with whey (WHEY) or a hydrolysed collagen blend (COLLAGEN) provision before, during 108 
and after exercise. At 36-40 h prior to the main experimental trials, all subjects performed a 109 
glycogen depletion protocol followed by 36 h of low CHO (3 g.kg.d-1) and energy intake (~7.58 110 
± 0.6 MJ.day-1) (as replicated from Impey et al. 2016) in order to standardise pre-exercise 111 
muscle glycogen content (see Figure 1). Subjects refrained from CHO intake on the morning 112 
of the main experimental trial as well as during exercise, but consumed 1.2 g/kg body mass 113 
(BM) of CHO split across two equal 0.6 g/kg doses at 30 min and 60 min post exercise in both 114 
trials.  Subjects consumed 22 g of whey or collagen protein at 45 minutes prior to exercise, 22 115 
g during exercise and a further 22 g immediately post-exercise. Both trials represented 116 
deliberate conditions of reduced CHO and absolute energy availability, but with high protein 117 
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availability in the form of whey or collagen throughout. Muscle biopsies were obtained from 118 
the vastus lateralis immediately pre-, post- and at 1.5 h post-exercise.  119 
Assessment of peak oxygen uptake: Participants were assessed for peak oxygen consumption 120 
(VO2peak) and peak aerobic power (PPO) as determined during an incremental cycle test 121 
performed on an electromagnetically braked cycle ergometer as previously described (Impey 122 
et al. 2015).  123 
Experimental Protocol: 124 
Day 1 and 2: Participants arrived at the laboratory on the evening (17.00) of day 1. Subjects 125 
then performed an intermittent glycogen-depleting cycling protocol lasting ~120 min ( as 126 
described by Impey et al. 2016). This protocol and all subsequent cycling protocols were 127 
conducted on a fully adjustable electromagnetically braked cycle ergometer (Lode Excalibur, 128 
Netherlands). The activity pattern and total time to exhaustion (115 ± 5 min; Energy expenditure: 129 
1444 ± 107 kJ) were recorded and repeated exactly during the second experimental condition. 130 
Participants then consumed a diet low in carbohydrate (3 g.kg-1 BM) but high in protein (2 131 
g.kg-1 BM) over the next 36 h to minimise muscle glycogen replenishment to ~300-350 132 
mmol.kg-1 dw on the morning of the main experimental trial.  During this 36 h period prior to 133 
the main experimental trial, total energy intake equated to 7.58 ± 0.6 MJ.  Estimated energy 134 
expenditure (as calculated from resting metabolic rate using the Harris Benedict equation and 135 
PAL level of 1.4 for the sedentary period on Day 2) was 15. 9 ± 1.1 MJ and hence energy 136 
balance was – 8.4 ± 0.45 MJ. 137 
Day 3: Subjects reported to the laboratory in a fasted state and an indwelling cannula (Safety 138 
Lock 22G, BD Biosciences, West Sussex UK) was inserted into the anticubital vein in the 139 
anterior crease of the forearm.  Blood samples were collected immediately prior to and every 140 
15 minutes during exercise as well as at 30 minute intervals in the recovery period from 141 
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exercise. Subjects consumed 22 g of protein from one of two commercially available products 142 
consisting of a hydrolysed collagen blend in a gel format (COLLAGEN: Muscle Gel, Muscle 143 
Pharm, USA; Ingredients: water, hydrolysed collagen, whey protein isolate, dietary fibre, 144 
natural flavours, citric acid, ascorbic acid, malic acid, niacinamide, sodium benzoate, 145 
potassium sorbate, sucralose, calcium D pantothenate, pyridoxine HCL, riboflavin) or a whey 146 
protein solution (WHEY: Whey Protein, Science in Sport, Nelson, UK; Ingredients: whey 147 
protein concentrate, whey protein isolate, fat reduced cocoa powder, natural flavourings, 148 
xanthan gum, soy lecithin, sucralose) at 45 minutes prior to beginning exercise. Due to the 149 
clear differences in delivery methods of protein sources (i.e. gel versus solutions), neither 150 
single nor double blinding of treatments occurred.  Fluid intake was matched in both conditions 151 
to 500 ml at this time-point. Subjects then rested for 45 minutes prior to commencing exercise. 152 
Protein was given 45 min prior to exercise in an attempt to maintain elevated circulatory amino 153 
acid availability during the exercise protocol (Impey et al. 2015). Following a 5 min warm up 154 
at 150 W, subjects then completed a prescribed cycling protocol consisting of 4 x 30 seconds 155 
high intensity intervals at 200% PPO interspersed with 2.5 min active recovery at 40% PPO, 156 
followed by 45 min steady state cycling at 60% PPO and finally, 3 x 3min intervals at 90% 157 
PPO. During the HIT and steady state component, subjects ingested 7.3g of COLLAGEN or 158 
WHEY protein every 20 min to provide 22 g of protein per hour.  Physiological and perceptual 159 
measures were recorded at regular intervals throughout exercise (e.g. heart rate, RPE) and 160 
substrate utilisation was assessed during the steady state component of the exercise protocol 161 
using online gas analysis (CPX Ultima, Medgraphics, Minnesota, US) according to Jeukendrup 162 
and Wallis (2005).  Following completion of the training session, subjects consumed an 163 
additional 22 g of COLLAGEN or WHEY protein immediately post-exercise as well as 164 
1.2g.kg-1 BM carbohydrate in the form of sports drinks (Science in Sport, Nelson, UK) and 165 
snacks (Jaffacakes, UK) split as equal doses of 0.6 g.kg-1 BM at 30 and 60 minutes post-166 
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exercise. Laboratory conditions remained constant across all experimental trials (19 – 21oC, 40 167 
– 50% humidity). 168 
Muscle biopsies: Muscle biopsies were obtained from separate incision sites (2 – 3 cm apart) 169 
from the lateral portion of the vastus lateralis muscle. Biopsies were obtained using a Bard 170 
Monopty Disposable Core Biopsy Instrument (12 guage x 10 cm length, Bard Biopsy Systems, 171 
Tempe, AZ, USA). Samples were obtained under local anaesthesia (0.5% marcaine) and 172 
immediately frozen in liquid nitrogen and stored at – 80oC for later analysis.  173 
Blood analysis: Blood samples were collected in vacutainers containing K2 EDTA, lithium 174 
heparin or serum separation tubes, and stored on ice or at room temperature until centrifugation 175 
at 1500 g for 15 min at 4 ̊C. Serum and plasma were aliquoted and stored at -80 ̊C until analysis. 176 
Plasma glucose, lactate, non-esterifed fatty acids (NEFA), glycerol, β-hydroxybutyrate (β-177 
OHB), insulin and amino acids were analysed as previously described (Impey et al. 2016).  178 
RNA extraction and analysis and Reverse transcriptase quantitative Real-Time 179 
Polymerase Chain Reaction (rt-qRT-PCR): Muscle samples (~ 20 mg) were immersed and 180 
homogenized in 1ml TRIzol (Thermo Fisher Scientific, UK). RNA was extracted according to 181 
the manufacturer’s instructions. RNA concentration and purity were assessed by UV 182 
spectroscopy at ODs of 260 and 280 nm using a Nanodrop 3000 (Fisher, Rosklide, Denmark). 183 
70 ng RNA was used for each PCR reaction. Primer were purchased from Sigma (Suffolk, UK) 184 
and forward (F) and reverse (R) sequences were as follows: PGC-1 (F: 185 
TGCATGAGTGTGTGCTCTGT; R: CAGCACACTCGATGTCACTC), p53 (F: 186 
ACCTATGGAAACTACTTCCTGAAA; R: CTGGCATTCTGGGAGCTTCA), Parkin (F: 187 
TCCCAGTGGAGGTCGATTCT; R: GGAACCCCCTGTCGCTTAG), Beclin1 (F: 188 
ATCTCGAGAAGGTCCAGGCT; R: TCTGGGCATAACGCATCTGG). rt-qRT-PCR 189 
amplifications were performed using QuantiFastTM SYBR® Green RT-PCR one step kit on a 190 
8 
 
 
Rotogene 3000Q (Qiagen, Crawley, UK) supported by rotogene software (Hercules, CA, 191 
USA).  Detailed procedures are described by Impey et al. (2016).  192 
Muscle glycogen concentration: Muscle glycogen concentration was determined from 10-20 193 
mg muscle tissue according to the acid hydrolysis method described previously (Impey et al. 194 
2016). Glucose concentrations were quantified using a commercially available kit (GLUC-HK, 195 
Randox Laboratories, Antrim, UK).  196 
[γ-32P] ATP Kinase Assay: Twenty mg muscle tissue was used for the measurement of 197 
p70S6K1 and PKB (Akt) activity as previously described (McGlory et al. 2014). 198 
Statistics: Statistical analyses were performed using Statistical Package for the Social Scientist 199 
(SPSS version 21). Changes in physiological and molecular responses between conditions (i.e. 200 
muscle glycogen, circulatory metabolites, amino acids, mRNA and kinase activity) were 201 
analysed using two way repeated measures General Linear Model, where the within factors 202 
were time and condition. Where a significant main effect was observed, pairwise comparisons 203 
were analysed according to Bonferoni post hoc tests in order to locate specific differences. A 204 
P value < 0.05 was deemed significant and all data in text, figures and tables are presented as 205 
mean ± SD. 206 
 207 
Results  208 
Physiological and metabolic responses to exercise 209 
Exercise intensity and substrate metabolism during the steady state component of the exercise 210 
protocol is displayed in Table 1. No significant differences (P>0.05) were observed between 211 
trials for any parameter.  Exercise reduced (P<0.001) muscle glycogen stores to comparable 212 
levels (150 mmol.kg-1 dw) with no difference (P=0.485) between conditions (Table 2).  Plasma 213 
9 
 
 
NEFA, glycerol and β-OHB increased during exercise (P<0.001) though plasma glucose did 214 
not display any change (P = 0.112) (Figure 2 A, B, C and D, respectively). Changes in plasma 215 
NEFA availability across the whole sampling period were suppressed in WHEY compared with 216 
the COLLAGEN trial (P=0.046) whereas no differences were observed between trials for 217 
glycerol (P=0.080), β-OHB (P = 0.070) or glucose (P=0.963).  Despite differences in NEFA 218 
availability during exercise, no differences were observed in either CHO (P=0.640) or lipid 219 
oxidation (P=0.750) during the steady state component of the exercise protocols (Table 1, 220 
respectively). 221 
Markers of mitochondrial adaptations 222 
The magnitude of the exercise-induced increase (P = 0.001) in PGC-1α mRNA expression at 223 
90 min post-exercise was not different (P = 0.731) between trials (Figure 3A). Neither exercise 224 
(P = 0.354) nor experimental condition (P = 0.472) affected p53 mRNA expression (Figure 225 
3B).  As markers of mitophagy, Parkin mRNA displayed no effect of exercise (P = 0.417) or 226 
experimental condition (P = 0.301), whereas Beclin 1 displayed a trend towards an effect of 227 
exercise (P = 0.058) but no effect of condition (P = 0.968).   228 
 229 
Plasma amino acids, serum insulin and p70S6K1 related signalling 230 
Plasma leucine, BCAAs and EAAs all displayed a significant main effect of time (P=0.043, 231 
0.028 and 0.021, respectively) during the sampling period (Figure 4 A, B, C respectively).  232 
Pairwise comparisons demonstrated that leucine and BCAAs were significantly different from 233 
pre-exercise after 30 and 45 minutes of exercise and that BCAAs were also different from pre-234 
exercise values after 30, 60 and 90 minutes of recovery.  Such main effects of time appear to 235 
be predominantly due to those changes occurring in the WHEY trial given that no differences 236 
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are apparent in the COLLAGEN trial.  Additionally, leucine (P=0.02) and BCAA 237 
concentrations (P=0.03) also demonstrated a main effect for condition such that WHEY was 238 
greater than COLLAGEN whereas differences in EAA between trials only approached 239 
statistical significance (P=0.060). When expressed as AUC data, only plasma leucine 240 
(P=0.025) was different between trials whereas AUC for BCAA (P=0.135) and EAA (P=0.062) 241 
were not different (data not shown).   242 
In accordance with post-exercise CHO intake, insulin increased from pre- and post-exercise 243 
values (P = 0.034) though the magnitude of change was not different between trials (P = 0.159) 244 
(Figure 4D).  As such, no difference (P=0.187) was apparent between trials for insulin AUC 245 
data (data now shown) 246 
PKB activity was elevated at 90 min post-exercise (P = 0.003) compared with pre-exercise 247 
values, irrespective of nutritional condition (P=0.370) (Figure 4E). Exercise suppressed 248 
(P=0.015) p70S6K activity to comparable levels immediately post-exercise (≈ 25 fmol.min-249 
1.mg-1).  However, post-exercise feeding increased p70S6K activity at 1.5 h post-exercise 250 
(P=0.004), the magnitude of which was greater (P=0.046) in WHEY (180 ± 105 fmol.min-1.mg-251 
1) versus COLLAGEN (73 ± 42 fmol.min-1.mg-1) (Figure 4F).   252 
 253 
Discussion  254 
We examined the effects of whey versus collagen protein on skeletal muscle cell signalling 255 
responses associated with mitochondrial biogenesis and protein synthesis in recovery from an 256 
acute training session completed with low CHO availability. We deliberately studied two forms 257 
of protein feeding that we consider have practical relevance for endurance athletes i.e. a whey 258 
protein solution versus a hydrolysed collagen blend administered in a gel format.  We also 259 
11 
 
 
adopted an acute training session intended to mimic situations in which endurance athletes 260 
deliberately train with low endogenous and exogenous CHO availability in an attempt to 261 
promote oxidative training adaptations (Impey et al. 2018).  Whilst we observed no effects of 262 
protein composition on acute adaptations associated with mitochondrial biogenesis, whey 263 
protein induced greater leucinemia and post-exercise activity of p70S6K activity than collagen. 264 
In accordance with the well-documented differences in amino acid composition between whey 265 
and collagen (Castellanos et al. 2006), we observed marked differences in the extent of 266 
leucinemia induced by the two protein feeding strategies.  In this regard, leucine was elevated 267 
to a greater extent with the whey protein solution when compared with the hydrolysed collagen 268 
gel format.  In agreement with previous reports from our laboratory (Taylor et al. 2013) and 269 
others (Breen et al. 2011), we observed that amino acid availability does not apparently 270 
modulate acute markers of mitochondrial adaptations.  In contrast, we observed whey protein 271 
induced greater increases in post-exercise p70S6K activity.  The effects of post-exercise whey 272 
protein consumption on activation of the mTOR-p70S6K pathway is well documented 273 
(Phillips, 2016) and hence, the greater effect of whey compared with collagen on activation of 274 
p70S6K is likely related to the increased leucine availability (Moberg et al. 2014; Apro et al. 275 
2015a). Nonetheless, we acknowledge that direct assessment of muscle protein synthesis using 276 
stable isotope or deuterium methods would have provided greater insight to the functional 277 
relevance of the nutritional strategies used here.  In addition, future studies could also assess if 278 
such divergent signalling responses are still apparent if the collagen formulation was fortified 279 
with additional leucine content to match that of the whey solution. 280 
Although we readily acknowledge that the total leucine delivery in the WHEY trial may appear 281 
excessive in terms of that required to facilitate protein synthesis as well as likely resulting in 282 
elevated leucine oxidation (as suggested by the fall in leucine and BCAA after 30 and 45 283 
minutes of exercise), we deliberately chose this dosing strategy for a number of practical 284 
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reasons. Firstly, given that exercising in CHO restricted states augments leucine oxidation 285 
(Lemon and Mullin, 1980; Wagenmakers et al. 1991; Howarth et al. 2009), it was our deliberate 286 
aim to administer higher exogenous leucine so as to deliver both substrate to promote muscle 287 
protein synthesis (Breen et al. 2011; Pasiakos et al. 2011; Churchward-Venne et al. 2013) but 288 
yet, also compensate for the higher levels of endogenous leucine oxidation (Lemon and Mullin, 289 
1980; Howarth et al. 2009).  Second, unpublished observations by the corresponding author on 290 
elite professional cyclists indicated that this is the type of protein feeding strategy actually 291 
adopted during morning training rides that are deliberately undertaken in the absence of CHO 292 
intake before and during exercise.  As such, our aim was to replicate these “real world” 293 
strategies and determine the effects of such high protein availability on substrate metabolism 294 
and post-exercise signalling responses.  Finally, given that many elite cyclists are potentially 295 
in daily energy deficits (Vogt et al. 2005) with low energy availability (Loucks et al. 2011), 296 
and also that 3 g/kg body mass of daily protein has been recommended to maintain lean mass 297 
during energy restriction (Stokes et al. 2018), we therefore considered this feeding strategy to 298 
be in accordance with daily protein intakes for both quantity and frequency (Areta et al. 2013).  299 
For example, over the 3.5 h data collection period (i.e. 9 am to 1230 pm), the present subjects 300 
(ranging from 70-80 kg) consumed 66 g protein and hence for the daily target to be achieved 301 
(i.e. approximately 210-240 g), our approach is therefore in accordance with a feeding strategy 302 
where subsequent 30-40 g doses could be consumed at 3 h intervals (e.g. 1, 3, 6 and 9 pm if 303 
required). 304 
When considered in combination with our recent data (Impey et al. 2016; Hammond et al. 305 
2016), the present study also adds to our understanding of the regulation of p70S6K activity 306 
both during and after exercise.  Indeed, whereas other researchers have reported that acute 307 
endurance exercise does not suppress post-exercise p70S6K phosphorylation (Coffey et al. 308 
2006) or activity (Apro et al. 2015b), we have consistently observed an exercise-induced 309 
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suppression in p70S6K activity. We suggest that such differences between studies may be due 310 
to the magnitude of energy deficit associated with the CHO restriction and glycogen taxing 311 
exercise protocols used both here and previously (Impey et al. 2016).  Indeed, whilst it is 312 
difficult to directly compare the total energy expenditure between this study and the data of 313 
Apro et al. (2015b), the exercise intervention studied here elicited considerably lower muscle 314 
glycogen concentrations (i.e. ~150 mmol.kg-1dw vs 350 mmol.kg-1dw).  The potential effects 315 
of low muscle glycogen availability on post-exercise signalling (albeit in response to resistance 316 
exercise) was also evidenced by Camera et al. (2012) who observed that low muscle glycogen 317 
availability (i.e. 150-200 mmol.kg-1dw) reduced mTOR phosphorylation compared with higher 318 
glycogen concentration (i.e. 350-400 mmol.kg-1dw). Nonetheless, these workers also observed 319 
the apparent disconnect between snapshots of cell signalling and functional outcomes given 320 
that glycogen concentrations did not affect myofibrillar protein synthesis. 321 
In relation to the re-activation of p70S6K activity in the recovery period from exercise, it is 322 
noteworthy that we previously observed that the sustained presence of reduced CHO (and 323 
energy availability) and/or high post-exercise fat availability also suppresses the re-activation 324 
of p70S6K1, even when leucine enriched whey protein was consumed in the post-exercise 325 
period (Impey et al. 2016).  Based on these studies, we therefore suggested that the apparent 326 
suppression of p70S6K1 activity may be due to 1) reduced insulin and PKB signalling or, 2) a 327 
direct effect of increased fat availability (Kimball et al. 2015) and/or reduced glycogen 328 
mediating suppression of mTORC1 complex via energetic stress related mechanisms. The 329 
present data lend support for the latter mechanism for several reasons.  First, we observed that 330 
the whey-induced increase in p70S6K1 activity when compared with collagen feeding was 331 
independent of post-exercise insulin and PKB activity.  Second, at the termination of exercise 332 
(i.e. the 75 min time point that corresponds low muscle glycogen availability and energy 333 
deficit) the absolute circulating NEFA concentrations observed in our collagen trial (i.e. 334 
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approximately 1.5 mmol.L-1) was similar to that achieved with both CHO restriction (Impey et 335 
al. 2016) and post-exercise high fat feeding protocols (Hammond et al. 2016). The apparent 336 
suppression of NEFA in the WHEY trial may be due to the higher insulin responses associated 337 
with feeding whey protein before and during exercise (Impey et al. 2015; Taylor et al. 2013), 338 
thereby causing a reduction in lipolysis that manifests itself as reduced circulating NEFA 339 
availability during the exercise period.  Nonetheless, we acknowledge that the current 340 
assessments of insulin concentration were limited to pre-and post-exercise time-points per se.  341 
We also acknowledge the limitations associated with making inferences on muscle free fatty 342 
acid (FFA) uptake on snapshot assessments of circulating NEFA per se.  Nonetheless, given 343 
recent data demonstrating that acute increases in fat availability (as achieved via lipid infusion 344 
protocols) impairs MPS in human skeletal muscle despite similar circulating insulin and 345 
leucine concentrations (Stephens et al. 2015), it remains possible that subtle alterations in FFA 346 
availability (as caused by “acute” dietary manipulations) can have associated implications on 347 
mTOR related signalling.  When considered with previous studies (Impey et al. 2016; 348 
Hammond et al. 2016), the present data suggest that in those exercise conditions in which 349 
muscle glycogen is near depletion, the beneficial effects of whey protein (i.e. leucine mediated 350 
activation of mTOR) are especially apparent when co-ingested with post-exercise CHO 351 
feeding. Whilst there may be benefits of commencing training with reduced endogenous and 352 
exogenous CHO availability, we suggest the post-exercise meal should contain a combination 353 
of both protein and CHO, the latter to provide the necessary substrate, energy and metabolic 354 
environment to stimulate cell signalling processes.  355 
In summary, we demonstrate that when in recovery from an acute training session undertaken 356 
with low CHO and energy availability, whey protein induces greater leucinemia and post-357 
exercise p70S6K activity compared with a hydrolysed collagen blend. Data suggest that 358 
hydrolysed collagen blends are a sub-optimal protein source in relation to the goal of 359 
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stimulating those signalling pathways that regulate muscle protein synthesis. Future studies are 360 
now required to directly assess the acute effects of whey versus collagen protein feeding on 361 
muscle protein synthesis as well as to examine the long-term effects of such feeding strategies 362 
on training-induced skeletal muscle adaptations and performance outcomes. 363 
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 512 
Figure 1. Schematic representation of the experimental design. On the evening of day 1, 513 
subjects completed a glycogen depleting protocol followed by consumption of 22 g of whey 514 
protein. Throughout the entirety of day 2, subjects consumed a low CHO and low energy 515 
dietary protocol that was matched for both protein and fat intake. During the main experimental 516 
trial on day 3, subjects ingested 22 g of collagen (COLLAGEN) or whey (WHEY) protein 517 
before, during and after completion of an acute train-low exercise protocol. In addition to 518 
protein, subjects also consumed CHO (0.6 g.kg-1 BM) at 30 min and 1 h post-exercise. Muscle 519 
biopsies were obtained immediately pre-exercise, post-exercise and 1.5 h post-exercise.  This 520 
experimental protocol represents an amalgamation of train-low paradigms as subjects 521 
effectively performed sleep low on the evening of day 1, consumed a low CHO diet on day 2 522 
and finally, completed an acute training session on the morning of day 3 with CHO restricted 523 
before and during exercise. 524 
 525 
Figure 2. Plasma (A) NEFA, (B) glycerol, (C) βOHB and (D) Glucose during and in recovery 526 
from exercise. Shaded area represents exercise duration. * P<0.05 significant difference from 527 
pre-exercise (i.e. time-point 0), ^ P<0.05 significant main effect of condition.  528 
 529 
Figure 3. mRNA expression of (A) PGC-1α, (B) p53, (C) Parkin and (D) Beclin1. * P<0.05 530 
significant difference from pre-exercise. 531 
 532 
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Figure 4. Plasma (A) leucine, (B) total BCAA, (C) total EAA and (D) insulin.  Kinase activity 533 
of (E) PKB and (F) p70S6K. Shaded area represents exercise duration. *P<0.05 significant 534 
difference from pre-exercise, **P<0.05 significant difference from post-exercise, ^P<0.05 535 
significant main effect of condition.  536 
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Table 1 – Exercise intensity and substrate metabolism during the steady state component of the 576 
exercise protocol. 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
 592 
 593 
 594 
 595 
 596 
 597 
                                                     
                                             Time (min) 
 15 30 45 
    
VO2 (% VO2max)    
WHEY 66 ± 1 67 ± 2 68 ± 2 
COLLAGEN 67 ± 2 67 ± 1 68 ± 1 
Heart Rate (b.min-1)    
WHEY 165 ± 12 167 ± 12 166 ± 12 
COLLAGEN 167 ± 6 168 ± 8 168 ± 8 
RER (AU)    
WHEY 0.86 ± 0.05 0.86 ± 0.05 0.86 ± 0.06 
COLLAGEN 0.86 ± 0.05 0.87 ± 0.03 0.86 ± 0.03 
CHO Oxidation (g.min-1)    
WHEY 1.9 ± 0.8 1.9 ± 0.8 1.9 ± 0.9 
COLLAGEN 2.1 ± 0.6 2.1 ± 0.6 2.1 ± 0.6 
Lipid Oxidation (g.min-1)    
WHEY 0.7 ± 0.4 0.7 ± 0.3 0.7 ± 0.4 
COLLAGEN   0.6 ± 0.2           0.6 ± 0.2     0.7 ± 0.2  
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Table 2 – Muscle glycogen concentration before and after exercise. * denotes significant different 598 
from pre-exercise, P<0.05. 599 
 600 
 601 
 602 
 603 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
 612 
                                                     
                                             Time (min) 
 Pre- Post- + 90 min 
    
Glycogen (mmol.kg-1 dw)    
WHEY 339 ± 66 158 ± 80 * 183 ± 35 * 
COLLAGEN 356 ± 44 141 ± 25 * 173 ± 23 * 
    
